Exchange-Traded Funds, US Equities Higher in Tuesday's Shortened Trading
Sector Update: Health Care Stocks Mixed Premarket Tuesday
How Is The Market Feeling About Alnylam Pharmaceuticals?
Mizuho CEO Sees Global Boom in M&A After Trump Takes Office
Schwab US Dividend Equity ETF Reverses In December: What's Going On?
Spotlight on Amgen: Analyzing the Surge in Options Activity
Vertex Pharmaceuticals: Alyftrek Is An 'Accretive Opportunity' On Top- And Bottom-Lines, Says Bullish Analyst
Microsoft To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Monday
2024's Top and Bottom Nasdaq-100 Performers Includes NVDA, APP, INTC, MRNA, and More
Waters Analyst Ratings
Sector Update: Health Care Stocks Fall Premarket Monday
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Monday as Investors Assess Fed's Interest Rate Outlook
SA Asks: Which Big Pharmas Are Likely to Announce Big M&A Deals?
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Novo Nordisk, Super Micro Computer And Arm Are Among Top Large Cap Losers Last Week (December 16-20): Are The Others In Your Portfolio?
Materials, Software Stocks Are Best Poised for H1 Outperformance: Goldman Sachs
Trending Stocks in Bearish Pre-holiday Week for U.S. Stock Market
Vertex Announces U.S. FDA Approval For TRIKAFTA To Include Additional Non-F508del TRIKAFTA-Responsive Variants
What's Going On With Amgen Stock On Friday?